CIDRAP newsletters options
The man infected at least two other people, and officials again stressed urgent steps.
China has confirmed a fatal H7N9 avian flu case in a 66-year-old woman, Hong Kong's Centre for Health Protection (CHP) said today.
The woman is from Xinjiang Uyghur Autonomous Region in the country's far northwest. The only other reported H7N9 case in the region, in a 53-year-old man, was confirmed last week. All other mainland H7N9 cases have been in eastern provinces, hundreds of miles away.
With 29 new infections, the DRC outbreak has grown to 53 cases and 31 deaths.
CDC director calls for immediate biodefense aid, and the FAO warns about Ebola-caused food shortages.
With 69,343 new cases, mostly from the Dominican Republic, the chikungunya outbreak in the Caribbean reached 658,466 cases last week, according to an Aug 29 update from the Pan American Health Organization (PAHO).
The US Department of Health and Human Services (HHS) will spend up to $42.3 million to help accelerate development of the experimental Ebola drug ZMapp, the agency said in a press release today.
Cilantro grown in the Puebla, Mexico, area is suspected as the cause of some cases in a summer outbreak of Cyclospora infections in Texas.
A recent vaccinia infection in a US Air Force trainee was facilitated by shaving and caused serious facial lesions that required a long hospital stay.
Senegal announced today the country's first Ebola virus disease case, in a student from Guinea who was located in a Dakar hospital.
Ohio health officials have reported another variant H3N2 (H3N2v) infection, the nation's second such case this year, the US Centers for Disease Control and Prevention (CDC) said today.
The White House Office of Science and Technology Policy (OSTP) said yesterday that it has requested US researchers to conduct a "safety stand-down" to assess stocks of potentially dangerous pathogens and outlined longer-term steps to ensure lab biosecurity.
Twenty-six patients spread the virus to 12 contacts total, only 1 of whom got sick.
With an estimated price tag of $490 million, the plan's goal is to stop Ebola transmission in 6 to 9 months.
Vaccination coverage of young US children against all routinely recommended vaccines remained high and even increased for certain vaccines last year, according to data from the National Immunization Survey (NIS), published today in Morbidity Mortality Weekly Report (MMWR).
The National Institutes of Health (NIH) has partnered with an international-based consortium based in Britain to fast-forward work on an Ebola virus vaccine developed by GSK that has shown promise in nonhuman primate studies.
In addition, Canada pulled a lab team from Sierra Leone.
The first patient in the DRC's Ebola outbreak caught the virus from a dead animal, making any link to West Africa's outbreak unlikely.
The US government plans to request that federally funded laboratories suspend all work on potentially dangerous pathogens for about 24 hours to inventory stocks of microbes, ScienceInsider reported today.
Sequence analysis of human and environmental samples demonstrated that four strains of reassorted H7N9 avian flu viruses have been circulating in Guangdong province—one of the country's hardest hit—and that an increase of human cases last year coincided with an increase in H7 isolates in environmental samples, according to a study today in Emerging Infectious Diseases.
The WHO sent a team to a hot spot where one of its Ebola workers was infected.
